Stanley T. Crooke, Chairman and CEO at IONIS PHARMACEUTICALS INC (IONS), sold 77,000 shares at $60.07 ($4.7M) on 2019-02-25, disclosed to the SEC on 2019-02-27.
Open-market sale of $4.7M IONS by Chairman and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.07 | 40,000 | $2.4M | 51.3% |
| 2 | $61.54 | 37,000 | $2.3M | 48.7% |
| Total | $60.77 avg | 77,000 | $4.7M | 100% |
| Filing → |
| IONS | SELL | 2020-12-17 | $2.1M | — | Filing → |
| IONS | SELL | 2020-12-09 | $568K | — | Filing → |
| IONS | SELL | 2020-11-30 | $1.3M | — | Filing → |